The effect of tamoxifen on the genital tract (Q34593808)

3 August 2017

1 reference

15 October 2020

The effect of tamoxifen on the genital tract (English)

1 reference

female urogenital disease

3 August 2017

main subject

1 reference

15 October 2020

1 reference

7 November 2019

1 reference

15 October 2020

hormonal antineoplastic agent

1 reference

15 October 2020

Sandra A Polin

1

1 reference

3 August 2017

Susan M Ascher

series ordinal

2

1 reference

3 August 2017

language of work or name

1 reference

30 June 2008

7 references

3 August 2017

13 March 2019

3 April 2019

17 June 2019

7 November 2019

29 May 2020

15 October 2020

4 references

3 August 2017

17 June 2019

7 November 2019

15 October 2020

8

1 reference

3 August 2017

page(s)

135-145

1 reference

Tamoxifen and endometrial cancer. Is screening necessary? A review of the literature

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Endometrial pathologies associated with postmenopausal tamoxifen treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

The effects of tamoxifen on the female genital tract

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Effects of tamoxifen on the human female genital tract: review of the literature.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Tamoxifen treatment and gynecologic side effects: a review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Guidelines for monitoring patients taking tamoxifen treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Tamoxifen-induced uterine abnormalities: the role of imaging

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Gynaecological effects of tamoxifen

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Effect of tamoxifen on sexual functioning in patients with breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/Progestin Interventions Trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Tamoxifen and endometrial neoplasia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Breast cancer survivors: psychosocial concerns and quality of life

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

The effect of tamoxifen on the endometrium.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Pathology of endometrium treated with tamoxifen

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Postmenopausal tamoxifen treatment and endometrial pathology

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer--preliminary report

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Carcinoma of the uterus: use of gadopentetate dimeglumine in MR imaging

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Oestrogen-like effect of tamoxifen on vaginal epithelium

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Sonohysterography Compared With Endometrial Biopsy for Evaluation of the Endometrium in Tamoxifen‐Treated Women

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Transvaginal US and hysterosonography in postmenopausal women with breast cancer receiving tamoxifen: correlation with hysteroscopy and pathologic study

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Endometrial evaluation with transvaginal US and hysterosonography in asymptomatic postmenopausal women with breast cancer receiving tamoxifen

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Tamoxifen and risk of endometrial cancer

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Surveillance for uterine abnormalities in tamoxifen-treated breast carcinoma survivors: a community based study.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Effects of tamoxifen on the cytology of the uterine cervix in breast cancer patients

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Uterine side effects of tamoxifen: a need for systematic pretreatment screening

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Estimating the depth of myometrial involvement by endometrial carcinoma: efficacy of transvaginal sonography vs MR imaging.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Assessing myometrial invasion by endometrial carcinoma with dynamic MRI.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Comparison of transvaginal sonography with endometrial biopsy in asymptomatic postmenopausal women

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Change in endometrial thickness in postmenopausal women undergoing hormone replacement therapy

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2482152

Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings

9 December 2018

1 reference

12 December 2020

Incidence of New Primary Cancers After Adjuvant Tamoxifen Therapy and Radiotherapy for Early Breast Cancer

1 reference

12 December 2020

Transvaginal US appearance of endometrial abnormalities

1 reference

12 December 2020

ACOG committee opinion. No. 336: Tamoxifen and uterine cancer

1 reference

12 December 2020

Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding — a Nordic multicenter study

1 reference

12 December 2020

Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen

1 reference

12 December 2020

Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients

1 reference

12 December 2020

New synthetic agent for the induction of ovulation: preliminary trials in women

1 reference

12 December 2020

Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium

1 reference

12 December 2020

Endometrial thickness and Doppler velocimetry of the uterine arteries as discriminators of endometrial status in women with postmenopausal bleeding: a comparative study

1 reference

12 December 2020

Sensitivity and specificity of sonohysterography for the evaluation of the uterine cavity in perimenopausal patients

1 reference

12 December 2020

Endometrial thickness in tamoxifen-treated patients: an independent predictor of endometrial disease

1 reference

12 December 2020

Population-Based Study of Tamoxifen Therapy and Subsequent Ovarian, Endometrial, and Breast Cancers

1 reference

12 December 2020

Tamoxifen induced adenomyosis and adenomyomatous endometrial polyp

1 reference

12 December 2020

Tamoxifen in the treatment of breast cancer

1 reference

12 December 2020

Risk of endometrial cancer after tamoxifen treatment of breast cancer

1 reference

12 December 2020

Tamoxifen and risk of endometrial cancer

1 reference

12 December 2020

Should tamoxifen users be screened for endometrial lesions?

1 reference

12 December 2020

Estrogenic action of tamoxifen in women treated with luteinizing hormone-releasing hormone agonists (goserelin)--lack of shrinkage of uterine fibroids

1 reference

12 December 2020

Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients

1 reference

12 December 2020

Transvaginal saline hysterosonography: characteristics distinguishing malignant and various benign conditions

1 reference

12 December 2020

Sonohysterography: a technique for endometrial evaluation

1 reference

12 December 2020

Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen

1 reference

12 December 2020

Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients

1 reference

12 December 2020

Estrogen-Like Action of Tamoxifen on Vaginal Epithelium in Breast Cancer Patients

1 reference

12 December 2020

Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial

1 reference

12 December 2020

Rapid growth of leiomyoma in patient receiving tamoxifen

1 reference

12 December 2020

Endometrial carcinoma staging by MR imaging

1 reference

12 December 2020

Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation

1 reference

12 December 2020

Sonohysterography: evaluation of endometrial and myometrial abnormalities

1 reference

12 December 2020

Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen

1 reference

12 December 2020

Vaginal absorption of two estriol preparations. A comparative study in postmenopausal women

1 reference

12 December 2020

Association between endometrial cancer and tamoxifen treatment of breast cancer

1 reference

12 December 2020

The role of transvaginal sonography and endometrial biopsy in the evaluation of peri- and postmenopausal bleeding

1 reference

12 December 2020

Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening

1 reference

12 December 2020

Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen

1 reference

12 December 2020

MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: histopathologic correlation

1 reference

12 December 2020

Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality

1 reference

12 December 2020

Use of intracavity saline instillation and transvaginal ultrasonography to detect tamoxifen-associated endometrial polyps

1 reference

12 December 2020

Longitudinal hysteroscopic follow-up during tamoxifen treatment

1 reference

12 December 2020

Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound

1 reference

12 December 2020

Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen

1 reference

12 December 2020

10.1102/1470-7330.2008.0020

Identifiers

DOI

1 reference

release_lgkjmsgpqnb7tcwf7ujrjazh5y

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lgkjmsgpqnb7tcwf7ujrjazh5y

24 November 2022

mapped directly with Wikidata item

PMC publication ID

2482152

1 reference

3 August 2017

1 reference